This study represents a comparison of conventional transabdominal and transvaginal ultrasound and 3D transvaginal ultrasound in the evaluation of first trimester nuchal translucency. The 2D sonographic examinations were performed on 417 women with singleton pregnancies for evaluation of first trimester nuchal translucency. The 3D volumes were obtained using a transvaginal probe in 235 of the cases. In 208 of the 235 patients, the nuchal translucency was obtained with 3D transvaginal transducer. The nuchal translucency is an excellent screening tool used in the first trimester to evaluate the fetus for aneuploidy and other fetal structural abnormalities. The 3D transvaginal ultrasound can obtain the desired image in less time and more efficiently then changing and repositioning the patient. Key words: nuchal translucency, first trimester, 3D transvaginal ultrasound, transabdominal and transvaginal ultrasound
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Ultrasound is widely used for the evaluation of the fetus in the second trimester as a screening tool for abnormalities including markers for Down syndrome (trisomy 21). Down syndrome can affect any woman, regardless of age, family history, or health. The risk for a variety of chromosomal abnormalities increases with advancing maternal age. Many women have an alpha feto protein test or triple screen in the second trimester between 15 and 20 weeks. Down syndrome can be detected in 60% to 65% of pregnancies with this blood test. However, ultrasound is now being used to evaluate the fetus in the first trimester by evaluating the nuchal translucency (NT) as an early screening tool for Down syndrome.
The objective of this study is to demonstrate that 3D transvaginal ultrasound can increase the rate of visualization of the nuchal translucency and reproducibility of the measurement, as well as provide increased resolution over conventional transabdominal 2D images (see Fig. 1 ).
Material and Methods
The study included 417 women with singleton pregnancies that were undergoing screening at 10 to 14 weeks gestation from February 2000 to February 2001. In each case, 2D transvaginal sonography was performed. The crown-rump length (CRL) was measured to verify gestational age and correlate with the last menstrual period. In 235 of the women undergoing screening, the nuchal translucency was not obtained by 2D transvaginal scanning after 10 to 15 minutes and with manual manipulation of the uterus. A transabdominal scan was then performed to complete the study to obtain the nuchal translucency. Prior to the transabdominal scan, several 3D sweeps were made of the fetus at the level of the NT, in the area of the cervical spine. The ultrasound equipment used in this study included the VOLUSON 530 and VOLUSON 530 MT (Kretztechnik, Zipf, Austria) with 6.5 MHz transvaginal and 4.5 MHz transabdominal transducers.
In all 235 cases, 3D transvaginal ultrasound was performed with the bladder empty. In 208 cases, the 3D transvaginal images demonstrated the nuchal translucency in the midsagittal plane, with an optimal area for the measurement. We were unable to duplicate the 100% reported by Chung et al. 1 -our result was 88.5%. The nuchal translucency was imaged with a Bmode scanner that monitors spatial orientation of the images and saves these images as a volume set in the memory of a computer. The volume mode was turned on, and the 3D ultrasound volume was generated by automatic rotation through 360°. The largest sweep angle of the transducer was 95°. The volume scanning time was short (between 2 and 3 seconds), so no fetal movement was recorded on the sweep.
The volume data were stored on Sony 540-MB removal disks. The 3D ultrasound was completed in less than 3 minutes, and measurements of the nuchal translucency were taken from the stored volumes after the completion of the study. The 3D volume scanning acquires 3D volume data of the fetal neck. Then, a quality midsagittal view of the fetal neck can be acquired from the 3D data and sonographers can measure the nuchal translucency after the patient has left the scanning room. The 3D volumes can aid in distinguishing the amnion from the nuchal translucency. The measurements were obtained from the saved volume and by adjusting the fetal position using the multiplanar images.
There are 3 orthogonal axial planes displayed on the screen. Three sectional planes of 3D ultrasound are to be perpendicularly crossed with one another at the 3axial centers of rotation. The center of rotation is fixed on the midline of the fetal neck on the A plane (upper left). The A plane represented a frontal view of the fetus, the B plane demonstrated a midsagittal view, and the C plane represented an axial view of the nuchal translucency. 1 These planes were reformatted and rotated for the precise measurement of the nuchal translucency in the midsagittal view of the fetus. These calculations took about 15 minutes after the completion of the study. There was no loss of resolution from the 3D ultrasound, since the fetus remained close to the ultrasound beam and a higher frequency transducer was used, improving the resolution of the images. A second sonographer reviewed random acquisitions for accuracy of the nuchal translucency measurements, but no comparison was done by the sonographers.
The transabdominal transducer was then used to obtain an image of the nuchal translucency. The resolution was of a poorer quality due to the decrease in transducer frequency (6.5 MHz to 4.5 MHz) as well as an increase in the depth of the fetus from the transducer and maternal habitus. In the 235 patients 2D transabdominal scanning was used to obtain the nuchal translucency because conventional 2D transvaginal ul- trasound was unsuccessful. However, the image quality was at the low end of the image spectrum, and there was some difficulty in optimal visualization of the image due to magnification. In 208 of 235 (88.5%) of the patients, the nuchal translucency was obtained with the 3D transvaginal transducer with improved resolution and reproducibility (see Fig. 2 ).
Results
The 2D transabdominal nuchal translucency was obtained in 235 patients in the study that was not obtainable using conventional transvaginal ultrasound. In 208 of these patients, the nuchal translucency was obtained with 3D transvaginal transducer with subjectively improved resolution and reproducibility. In 88.5% (208/235) of cases, the 3D transvaginal images demonstrated the nuchal translucency in the midsagittal plane, with an optimal area for measurement after the volume data were reconstructed using multiplanar imaging and after repositioning the fetus. These images were subjectively superior to the transabdominal images taken moments later.
Discussion
The nuchal translucency is a normal space between the back of the fetal neck and the overlying skin and can be visualized between 10 and 14 weeks. An in-crease in the thickness of the nuchal translucency, seen on first trimester ultrasound, has been associated with aneuploidy and other fetal structural abnormalities. The preferable view of the fetus for the nuchal translucency measurement is the CRL in the midsagittal plane. The fetus should be away from the amniotic membrane to distinguish between amnion and fetal skin, with the fetal image occupying three quarters of the screen. 2 Presently, a measurement above 3.0 or 3.5 mm from inner to inner in the anterior-posterior dimension is an indicator for fetal chromosomal abnormalities between 10 and 14 weeks gestation.
Although 3D ultrasound has been widely used in Europe for years, it is beginning to change the way ultrasound exams are done in the United States. 3D ultrasounds are quick and efficient. The image can be taken in a different plane and then reconstructed to provide the image needed without changing transducers or waiting for fetal position to change. There is no increased study time resulting from changing transducers and readjusting the patient for transabdominal ultrasound and no loss of resolution due to increase in depth from maternal habitus and lower frequency transducers, and accurate measurements of the nuchal translucency can be made quickly (see Fig. 3 ).
Screening for increased nuchal translucency in the general public should have established guidelines, current ultrasound equipment with quality image resolution, and appropriate training. There are certain limitations of nuchal translucency measurement by conventional or 2D ultrasound. These include suboptimal fetal position, the small size of the structure to be measured, the nuchal region resting on the amniotic membrane, the incorrect median sagittal section of the fetus, and loss of resolution due to the increased depth of transabdominal scanning and decreased transducer frequency. These factors can lead investigators to high rates of failure as well as poor reproducibility of the measurement. 1 The use of 3D ultrasound can overcome the nonvisualization and poor reproducibility of the nuchal translucency.
Experienced sonographers and sonologists trained in nuchal translucency acquisition and measurement techniques, as well as the volume acquisition scan, should perform the 3D ultrasounds. The acquisition and measurement of the nuchal translucency and volume acquisition scans require that ultrasound professionals be properly trained in 3D ultrasound techniques (see Fig. 4 ).
In conclusion, measuring the nuchal translucency is technically uncomplicated. There can be up to 18% failure rate and poor reproducibility of the measurements as reported by Roberts et al. 1 The 3D transvaginal ultrasound allows a nearly perfect midsagittal view of the fetus, in spite of suboptimal fetal position, without the need to change from a 2D transvaginal transducer to a transabdominal transducer. There is no loss of resolution and no delay in scanning time, and accurate measurements of the nuchal translucency are obtained. This is an extremely useful tool in early screening for aneuploidies, such as trisomy 21, which is one of the most common, serious abnormalities found at birth and occurs in 1.4 per 1000 births.
